Skip to main content
Caplight Logo









OPSYON Therapeutics

OPSYON Therapeutics

Private
ViennaHealthcare & Life Scienceshttps://opsyon.com/

Last Round

Grant

Apr 1, 2022

Company Overview

OPSYON Therapeutics is a biotechnology company that is a preclinical stage biopharmaceutical company focused on the development of first-in-class therapeutics for immunological and oncological diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

immuno-oncologycheckpoint inhibitorCD47-SIRPα pathwayantibody therapytumor-specific targeting'don't eat me' signalAcute Myeloid LeukemiaAMLcancer immunotherapySIRPα fusion proteinCD47 inhibitorsolid tumorsdrug discoverypancreatic cancerovarian cancer

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OPSYON Therapeutics Comparables

Compare OPSYON Therapeutics with similar companies based on industry and business-model similarity.

OPSYON Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sairopa B.V.
81%
HanchorBio, Inc.
78%
Molecular Partners AG
76%

OPSYON Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 1, 2022

OPSYON Therapeutics Investors

Notable investors and investment history

OPSYON Therapeutics investors
InvestorRounds
Federal Ministry for Economic Affairs and EnergyGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2022

    Received grant funding from European Social Fund Plus and the German Federal Ministry.

OPSYON Therapeutics Filings

Explore SEC and related filing metadata, where available.

OPSYON Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about OPSYON Therapeutics's valuation, stock price, and market status.

Is OPSYON Therapeutics a public or private company?

OPSYON Therapeutics is a private company.

What is the current stock price of OPSYON Therapeutics?

OPSYON Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is OPSYON Therapeutics worth (valuation)?

Valuation information for OPSYON Therapeutics is not publicly available.

Can I buy OPSYON Therapeutics stock?

OPSYON Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was OPSYON Therapeutics's last funding round?

OPSYON Therapeutics's most recent funding round was Pre Seed on April 6, 2022.

Who are the main investors in OPSYON Therapeutics?

Key investors in OPSYON Therapeutics include Federal Ministry for Economic Affairs and Energy.

Will OPSYON Therapeutics IPO soon?

No public IPO plans have been announced for OPSYON Therapeutics.

How can I track OPSYON Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OPSYON Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersVienna
Year Founded2021
Last FundingApr 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?